Table 1.
Characteristics of patients with HT and healthy controls.
| HT | HT-A | HT-B | Healthy control | Normal range |
|
|---|---|---|---|---|---|
| Cases (n) | 40 | 22 | 18 | 30 | — |
| Gender (F/M) | 35/5 | 19/3 | 16/2 | 26/4 | — |
| Age (years) | 28.93 ± 8.30 | 28.91 ± 9.21 | 28.94 ± 7.30 | 30.97 ± 6.39 | — |
| TSH (mIU/L) | 4.13 (1.82–6.25)** | 1.94 (0.99–3.06) | 6.95 (5.12–16.18)** | 1.89 (1.15–2.59) | 0.28–4.3 |
| FT3 (pmol/L) | 4.49 ± 1.32* | 4.97 ± 1.17 | 3.89 ± 1.27** | 5.23 ± 0.98 | 2.8–7.1 |
| FT4 (pmol/L) | 15.65 ± 3.04* | 16.58 ± 2.28 | 14.52 ± 3.50** | 17.29 ± 2.09 | 12–22 |
| TPOAb (IU/mL) | 200.00 (148.35–299.88)** | 171.00 (109.53–215.08)** | 294.75 (199.58–410.85)** | 14.25 (7.53–24.00) | 0–34 |
| TgAb (IU/mL) | 489.75 (300.70–774.70)** | 335.15 (258.85–485.48)** | 717.55 (551.53–1055.58)** | 51.00 (19.75–84.25) | 0–115 |
| MUI (μg/L) | 169.40 | 168.45 | 170.30 | 163.35 | — |
Data are shown as mean ± SD or median (25th–75th percentile) according to the distribution. HT-A, HT patient with normal thyroid function; HT-B, HT patient with subclinical or overt hypothyroidism; M, male; F, female; MUI, median of urine iodine. The P values represent different groups compared with healthy control (HC), *P < 0.05, **P < 0.01.